Chemoenzymatic Synthesis of Disialosyl Globopentaosylceramide (Dsgb5) to Study Its Binding to Siglec-7

<none>

Programme Social programme Plenary speakers Keynote speakers 1st EuroCarb Young Researcher (ECYR) Workshop CarboMet Workshop Mini symposium: Glycobiology at the LUMC and beyond Favourites/Agenda

Social programme

Plenary speakers

Keynote speakers

1st EuroCarb Young Researcher (ECYR) Workshop

CarboMet Workshop

Mini symposium: Glycobiology at the LUMC and beyond

Favourites/Agenda

Photos

Venue & Travel Venue Accommodation City of Leiden Travel directions

Venue

Accommodation

City of Leiden

Travel directions

Committees

Home

Chemoenzymatic Synthesis of Disialosyl Globopentaosylceramide (Dsgb5) to Study Its Binding to Siglec-7

Ingrid 't Hart , Geert-Jan Boons

1 Utrecht University, Utrecht, The Netherlands

Certain cancer cells are able to evade immune detection by decorating their cell surface with sialylated glycans [1]. The disialylated ganglioside disialosyl globopentaosylceramide (DSGb5, Fig 1) has been found on renal cancer cells and is correlated with a higher migration potential. A proposed mechanism of the immune evasion of DSGb5 is by binding sialic acid-binding immunoglobulin-type lectin (Siglec)-7 on NK-cells. Siglec-7 is a surface receptor which, upon ligand binding, inhibits an immune response through its intracellular tyrosine-based inhibition motif (ITIM) domain. So far, DSGb5 binding to Siglec-7 has only been studied in cell systems [2,3]. Knowing how pure DSGb5 binds Siglec-7 will give us insight on important structural features and can help us to design an possible inhibitor.

To obtain enough pure of the ganglioside an chemical synthetic approach is proposed for the core pentasaccharide Gb5. Neuraminic acids, however, are known to be difficult to handle in chemical synthesis due to the deactivating C-1 carboxylic acid on the anomeric position and absence of participating groups at C-3. Therefore an enzymatic approach will be used to install these monosaccharides in a site- and stereoselective way. A linker was installed at the reducing end to immobilize the glycan on a NHS-activated microarray slides and binding with Siglec-7 will be studied.

Figure 1. Chemical structure of the DSGb5 saccharide.

Büll, C.; Stoel, M. A.; den Brok, M. H.; Adema, G.J. Cancer Res. 2014, 15, 3199-3204

Ito, A.; Handa, K.; Withers, D. A.; Satoh, M.; Hakomori, S. FEBS Letters. 2001, 498, 116-120

Kawasaki, Y.; Ito, A.; Withers, D. A.; Taima, T.; Kakoi, N.; Saito, S.; Arai, Y. Glycobiology. 2010, 20, 1373-1379

Contact eurocarb@eurocarb2019.com for general questions about EUROCARB2019, or codee@eurocarb2019.com for scientific questions.

Leiden University / Leiden Institute of Chemistry lic.leidenuniv.nl

European Carbohydrate Organisation

Congress by Design www.congressbydesign.com